Associated Papers
miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1S expression.
Sessa R et al.
Open Biology, 2024
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Caprioli C et al.
Haematologica, 2021
32855275 (PubMed )
Supplement: 2020_252825_CAPRIOLI_SUPPL.pdf
Impact of GATA4 variants on stable warfarin doses in patients with prosthetic heart valves.
Jeong E et al.
The Pharmacogenomics Journal, 2015
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia.
Kanezaki R et al.
Blood, 2010
Select a paper to view details